During Matthew 13D/13G Filings for Ovid Therapeutics Inc. (OVID)

During Matthew 13D and 13G filings for Ovid Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
5:29 pm
Sale		 2021-12-31 13G Ovid Therapeutics Inc.
OVID		 During Matthew 3,103,932
4.500%		 -916,862decrease
(-22.80%)		 Filing
2021-02-16
4:39 pm
Sale		 2020-12-31 13G Ovid Therapeutics Inc.
OVID		 During Matthew 4,020,794
6.300%		 -964,811decrease
(-19.35%)		 Filing